ABSTRACT
BackgroundSystemic lupus erythematosus (SLE) is an autoimmune disease, which presents an immune disorder that leads to the production of autoantibodies with potential involvement of multiple organs. Infections are one of the most frequent causes of hospitalization and death in lupus patients, and SARS-CoV-2 infection has been a global threat since March 2020. Immunization of these patients has been strongly recommended, although vaccine evaluation studies have not included this profile of patients.ObjectivesTo evaluate the immunogenicity and safety after 2 doses of the vaccine against SARS-CoV2 in patients with SLE.MethodsSubgroup of SLE patients from the prospective multicenter cohort of patients with immune-mediated diseases "SAFER” – Safety and Efficacy on COVID-19 Vaccine in Rheumatic Disease, a phase IV study. Vaccination against SARS-CoV-2 took place with vaccines approved by Brazilian regulatory bodies CoronaVac (Inactivated SARS-CoV-2 Vaccine), ChadOx-1 (AstraZeneca) and BNT162b2 (Pfizer-BioNTech) and this project followed in line with the guidelines of the National Immunization Plan in Brazil. Patients aged 18 years or older with a previous diagnosis of SLE (according to the 2019 ACR/EULAR criteria) were included. Patients were evaluated by telephone contact and in a face-to-face visit on the 28th day after each dose. Patients were followed up by means of blood collection for measurement of IgG antibody against SARS-COV-2 by chemiluminescence and disease activity assessed using SLEDAI-2K score.ResultsA total of 367 individuals with SLE were included, of whom 207 received 2 doses of CoronaVac, 128 received 2 doses of ChadOx-1 and 32 received 2 doses of BNT162b2. 90% of the subjects were female with a mean age of 37 years. About 42% (154) of the individuals included did not have any other associated comorbidity. 50% (182) of patients were using oral glucocorticoids and azathioprine was the most frequent immunosuppressive therapy. Regarding disease activity parameters, 38% (140) of patients had zero SLEDAI-2K at baseline and 41% (147) had zero SLEDAI-2K 28 days after the 2nd dose. Anti-DNA positivity was 30.7% (16/52) at inclusion and 32.6% (17/52) 28 days after the 2nd dose. Complement consumption was present in 18% (10/55) at inclusion and in 14.5% (8/55) 28 days after the 2nd vaccine dose. The geometric mean titers of IgG antibodies against SARS-COV-2 increased in the different vaccine groups, log 2.27 BAU/mL at inclusion and log 5.58 BAU/mL 28 days after the 2nd dose. Antibody titers after second dose varied between different vaccines, 4.96 BAU/mL CoronaVac, 6.00 BAU/mL ChadOx-1 and 7.31 BAU/mL BNT162b2 vaccine, p < 0.001. Only 3.54% (13/367) patients had covid-19 infection after the 15th day of the second dose of immunization, 9 of them having received 2 doses of CoronaVac, 4 of them of ChadOx-1 and none of them receiving BNT162b2, with p-value of 0.63.ConclusionThis study suggests that vaccines against SARS-COV-2 are safe in SLE patients. Induction of immunogenicity occurred in different vaccine regimens. Only 3.5% of individuals had COVID-19 infection with no difference between the types of vaccines evaluated. Future analyzes to explore the association of the effect of immunosuppressive medication, as well as the impact of booster doses and longer follow-up on clinical outcome will be performed.References[1]Mason A, et al. Lupus, vaccinations and COVID-19: What we know now. Lupus. 2021;30(10):1541-1552.[2]Furer V, Eviatar T, Zisman D, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: A multicentre study. Ann Rheum Dis. 2021;80(10):1330-1338.[3]Izmirly PM, Kim MY, Samanovic M, et al. Evaluation of Immune Response and Disease Status in SLE Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. Published online 2021.Acknowledgements:NIL.Disclosure of InterestsNone Declared.
ABSTRACT
BackgroundPatients with immune-mediated rheumatic diseases (IMRDs) have been prioritized for COVID-19 vaccination to mitigate the infection severity risks. Patients with rheumatoid arthritis (RA) are at a high risk of severe COVID-19 outcomes, especially those under immunosuppression or with comorbidities associated. However, few studies in the literature assessed the safety and immunogenicity of the COVID-19 heterologous vaccine schedules in patients with RA.ObjectivesEvaluate the safety and immunogenicity of two heterologous vaccine schedules against SARS-CoV-2 in patients with RA.MethodsThese data are from the study "SAFER - Safety and Efficacy on COVID-19 Vaccine in Rheumatic Diseases,” a Brazilian multicentric prospective phase IV study to evaluate COVID-19 vaccine in IMRDs in Brazil. Immunogenicity and adverse events (AEs) in patients with RA of all centers were assessed after two doses of ChAdOx1 plus additional dose of BNT162b2 or after two doses of inactivated SARS-CoV-2 vaccine CoronaVac plus additional dose of BNT162b2. The titers of neutralizing antibodies against the receptor-biding domain of protein spike (S) of SARS-CoV-2 (anti-RBD) were measured by chemiluminescence test after each dose of immunizers. Proportions between groups were compared using the chi-square and Fisher's exact tests for categorical variables. Clinical Disease Activity Index (CDAI) before and after vaccination was assessed using the McNemar test.ResultsA total of 107 patients with RA were include in the study, most of them female, with a mean age of 46 years. Biological disease modifying anti-rheumatic drugs (DMARDs) were used by 50 % of the patients and conventional synthetics DMARDs in 48 %. Two doses of CoronaVac plus additional dose of BNT162b2 was used in 66 patients and two doses of ChAdOx1 plus additional dose of BNT162b2 in 41. Only mild AEs were observed, mainly after the first dose. The most common AEs after all doses, regardless of the immunizer type, were pain at the injection, headache, arthralgia and myalgia. ChAdOx1 had a higher frequency of pain at the injection (66% vs 32 %, p < 0,001) and arthralgia (68% vs 15%, p < 0,001) compared to CoronaVac. No patients had flare after the vaccination. The titers of anti-RBD after two doses of ChAdOx1 were higher compared to two doses of CoronaVac (6,03 BAU/mL vs 4,67 BAU/mL, p < 0,001). However, after the additional dose of BNT162b2, the anti-RBD titers were similar in both groups (7.28 BAU/mL vs 7.06 BAU/mL, p = 0.56). Only two cases of COVID 19, with mild symptoms, were reported, one in each group.Figure 1.ConclusionChAdOx1, CoronaVac, and BNT162b2 vaccines are safe in RA patients. The frequency of local adverse effects, particularly pain at the injection site, is high. AEs are more frequent with ChAdOx1, especially after the first dose. The use of the immunizers does not change the degree of inflammatory activity of the disease. The immunogenicity of the two heterologous regimens analyzed was similar.References[1]Marques C, Kakehasi AM, Gomides APM, Paiva EDS, Dos Reis Neto ET, Pileggi GCS, et al. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study. JMIR Res Protoc.[2]Medeiros-Ribeiro AC, Aikawa NE, Saad CGS, Yuki EFN, Pedrosa T, Fusco SRG, et al. Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial. Nat Med. 2021;27(10):1744-1751.[3]Machado PM, Lawson-Tovey S, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, et al. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Ann Rheum Dis. 2022;81(5):695-709.[4]Tavares ACFMG, Melo AKG, Cruz VA, Souza VA, Carvalho JS, Machado KLLL, et al. Guidelines on COVID-19 vaccination in patients with immunemediated rheumatic diseases: a Brazilian Society of Rheumatology task force. Adv Rheumatol. 2022;62:3.Acknowledg ments:NIL.Disclosure of InterestsNone Declared.
ABSTRACT
Objectives: To evaluate the safety and immunogenicity of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with Rheumatoid Arthritis (RA). Method(s): These data are from the 'SAFER (Safety and Efficacy on COVID-19 Vaccine in Rheumatic Diseases)' study, a Brazilian multicentric longitudinal phase IV study to evaluate COVID-19 vaccine in immunomediated rheumatic diseases (IMRDs). Adverse events (AEs) in patients with RA were assessed after two doses of ChAdOx1 or CoronaVac. Stratification of postvaccination AEs was performed using a diary, filled out daily. The titers of neutralizing antibodies against the receptor-biding domain of SARS-CoV-2 (anti-RBD) were measured by chemilumine scence test after each dose of immunizers. Proportions between groups were compared using the Chi-square and Fisher's exact tests for categorical variables. Clinical Disease Activity Index (CDAI) before and after vaccination was assessed using the McNemar test. Result(s): A total of 188 patients with RA were included in the study, most of them were female. CoronaVac was used in 109 patients and ChAdOx1 in 79. Only mild AEs were observed. The more common AEs after the first dose were pain at injection site (46,7%), headache (39,4%), arthralgia (39,4%) and myalgia (30,5%), and ChAdOx1 had a higher frequency of pain at the injection site (66% vs 32 %, p alpha 0.001) arthralgia (62% vs 22%, p alpha 0.001) and myalgia (45% vs 20%, p alpha 0.001) compared to CoronaVac. The more common AEs after the second dose were pain at the injection site (37%), arthralgia (31%), myalgia (23%) and headache (21%). Arthralgia (41,42 % vs 25 %, p = 0.02) and pain at injection site (51,43% vs 27%, p = 0.001) were more common with ChAdOx1. No patients had a flare after vaccination. The titers of anti-RBDafter two doses of ChAdOx1 were higher compared to two doses of CoronaVac (6,03 BAU/mL vs 4,67 BAU/mL, p alpha 0,001). Conclusion(s): The frequency of local adverse effects, particularly pain at injection site, was high. AEs were more frequent with ChAdOx1, especially after the first dose. The use of the immunizers dis not change the degree of inflammatory activity of the disease. In patients with RA, ChAdOx1 was more immunogenic than CoronaVac. .
ABSTRACT
Objectives: Systemic lupus erythematosus (SLE) is an autoimmune disease which presents infections as one of the most frequent complications, including more severe outcomes of Coronavirus disease 2019 (COVID-19). Immunization of these patients has been strongly recommended, however, data on safety are still scarce. In this study we evaluate the safety after vaccination against SARS-CoV2 in patients with SLE. Method(s): Safety and Efficacy on COVID-19 Vaccine in Rheumatic Disease - the 'SAFER' study, is a longitudinal Brazilian multicenter phase IV study. In this study patients with SLE (according to the 2019 ACR/EULAR criteria), older than 18 years who received vaccination against SARS-CoV-2 CoronaVac (Inactivated SARS-CoV-2 Vaccine), ChadOx-1 (AstraZeneca) and BNT162b2 (Pfizer-BioNTech) were included. The evaluation of adverse events (AEs) was done by telephone contact, symptom diaries and a face-to-face visit on the 28th day after each dose. Patients were followed up also by disease activity, assessed using SLEDAI-2 K score. Result(s): A total of 367 individuals with SLE were included, 207 received CoronaVac, 128 received ChadOx-1 and 32 received BNT162b2. Ninety percent of the subjects were female with a mean age of 37 years. About 50% (182) of patients were using oral glucocorticoids and azathioprine was the most frequent immunosuppressive therapy. Regarding disease activity parameters, 38%(140) of patients had zero SLEDAI-2Kat baseline and 41%(147) had zero SLEDAI-2 K 28 days after the 2nd dose. After the first and second dose the most frequent AEs were pain at injection site (58%/44%), headache (48%/33%) and pruritus (42%/37%). Comparing the three vaccines, after the first dose, local symptoms, myalgia, and fever were less frequent in patients who received CoronaVac (p alpha 0.001) as well as headache, tiredness (p = 0.001) and arthralgia (p = 0.003). After the second dose, only local symptoms such as pain at the application site and thickening of the skin around the application site were less frequent in the CoronaVac group (p alpha 0.05). Headache, tiredness, musculoskeletal symptoms and fever were more common in patients receiving AstraZeneca. No serious adverse events were reported regardless of the vaccination schedule used. Conclusion(s): This study suggests that vaccines against SARS-COV-2 are safe in SLE patients. Neither severe AEs were reported nor worsening of disease activity were reported. Comparing the different vaccines, CoronaVac had fewer adverse events.
ABSTRACT
The World Health Organization (WHO) has declared a public health pandemic state due to the trans-mission of the new coronavirus on March 11th, 2020. COVID-19, that is caused by SARS-CoV-2, has a very broad clinical spectrum, with predominantly respiratory symptoms developments. The role of the health professionals in fighting the pandemic requires the use of Personal Protective Equipment (PPE). PFF2 / N95 masks are suitable PPEs for this purpose. Due to the high demand for PFF2 / N95 masks to fight the pandemic, there was a shortage of this PPE world-wide. This work aims to present a characterization of the device called DELUX, utilized for UVC (ultra-violet C light spectra) sterilization of PFF2 / N95 masks, and allowing to extend the time of safe use of this PPE in emergency conditions. The photometric validation of the device resulted in the verification of the emission spectrum of the lamps used in the device, and the measurement of the optical power, demonstrating the adequacy of irradiation with UVC light, with a 15-minute cycle, and safely. Biological validation showed that DELUX is capable of inacti-vating SARS-CoV-2 present on the surface of PFF2 / N95 masks, thus being efficient for their sterilization. The safety offered by the sterilization cycle allows to extend the safe use of those masks. © 2022, Universidad Politecnica Salesiana. All rights reserved.
ABSTRACT
OBJECTIVES: While persistent symptoms have been reported after the coronavirus disease-2019 (COVID-19), long-term data on outpatients with mild COVID-19 are lacking. The objective was to describe symptoms persisting for 12 months. METHODS: This prospective cohort study on 1767 sailors of an aircraft carrier in which a Covid-19 outbreak occurred during a mission in April 2020 described predefined self-reported symptoms of Long-COVID at 6, 9 and 12 months. Logistic-regression analyses were used to identify correlates for Long-COVID at months 6, 9 and 12. RESULTS: Among the 641 participants, 619 (35%) completed at least one follow-up questionnaire (413 COVID-positive and 206 COVID-negative). Symptoms of Long-COVID were reported by 53.7%, 55.2% and 54.3% of COVID-positive participants vs 31.2%, 23.3% and 40.0% in COVID-negative patients, at 6 (p <.002), 9 (p <.002) and 12 months (p =.13), respectively. The most frequent symptoms reported were concentration and memory difficulties, asthenia and sleep disorders. CONCLUSION: In this study more than half of COVID-positive outpatients reported persistent symptoms up to 12 months post-quarantine. These findings suggests that all patients, including those with mild disease, can be affected by Long-COVID. A lack of difference at 12 months with COVID-negative patienys prompts caution. The symptoms of Long-COVID are so non-specific that they may be viewed as the consequence of multiple intercurrent factors.
Subject(s)
COVID-19 , Military Personnel , Humans , COVID-19/epidemiology , SARS-CoV-2 , Post-Acute COVID-19 Syndrome , Prospective Studies , Disease Outbreaks , AircraftABSTRACT
The Covid-19 pandemic has impacted society and its living spaces, especially the most vulnerable urban environments. In face of this pandemic, which has been going on for more than two years, the world population has had to adapt to the new ecosocial challenges spread by this global health crisis, especially with regard to urban solid waste. That said, the objective of the work was to analyze the scientific production on Covid-19 and its relationship with the management of urban solid waste, using a bibliometric approach and the content of publications between 2020 and 2022. The data were obtained through from the Web of Science, in a period from March to April 2022, from the titles, s and keywords analyzed using the VOSviewer software. The results revealed a significant growth in scientific production, with a progress of 329% between 2020 and 2021. From the total of 93 publications, the challenges, impacts, recycling and management of urban solid waste were the most debated topics among the productions scientific studies included in this bibliometric study, with an international dimension. It was found, therefore, that the urban waste generated with the pandemic is also vehicles for the transmission of the coronavirus, representing a risk to the population and social actors who act directly in the different forms of collection, treatment and final destination. However, as a limitation of the study, it was also found the need for empirical research that includes the perception of social actors regarding the generation and management of urban solid waste.
ABSTRACT
In the early seventeenth century, smallpox was one of the most fearsome communicable diseases in the world. Lady Mary Montagu noted that the disease could be prevented by introducing liquid extracted from smallpox scabs from an infected patient into the skin of healthy individuals. This process, known as “variolation” was used in England and in USA until the first investigations by the English physician Edward Jenner appeared. Jenner created the vaccine for an animal poxvirus from the pustule formed by the vaccinia virus in the teats of cows, where the technique was essentially based on the idea that a virulent agent for animals could be attenuated in humans. In 1885, Louis Pasteur, through a fixed virus which was obtained by successive passages in the nervous tissue of rabbits with the dissecting action of potassium hydroxide, developed the vaccine against rabies, in which similar procedures were adopted in the development of several vaccines of live attenuated viruses. Already in the 1940s, a revolution occurred with the discovery that cells could be cultured in vitro and used as substrates for viral growth. Oral polio vaccine and vaccines against measles, rubella, mumps and chickenpox were made possible by selecting clones by passage in in vitro cell culture. Some RNA virus have segmented genomes that can be manipulated. Co-cultivation of two virus in cell culture with clone selection by plaque formation allows the isolation of virus with segments from both. This regrouping planned to create three main vaccines: live and inactivated influenza as well as one of two rotavirus vaccines. Another discovery in the late nineteenth century was that immunogenicity could be maintained as the substance contained in those killed by heat or chemical treatment. This type of inactivation was first applied to pathogens of typhoid fever, plague and cholera bacilli. In the twentieth century, chemical inactivation was also applied to a virus. The influenza vaccine was the first successful inactivated virus vaccine, developed against Polio and Hepatitis A. Besides, several vaccines consist of partially or fully purified proteins. Most of the inactivated flu vaccines used are created by growing the virus in embryonated eggs and then breaking down the entire virus with detergents. The viral hemagglutinin protein is purified to serve as the vaccine antigen, although other influenza virus components may be part of the final product. Early in the history of bacteriology, morphological studies and chemical analyzes showed that many pathogens were surrounded by a polysaccharide capsule and that antibodies against the capsule could promote phagocytosis. The first use of this information to create a vaccine was the development of the meningococcal polysaccharide vaccine. After years of study and development in bacterology, the scientific community faced the Covid-19 pandemic in 2020, marked by the race against time in the invention of effective vaccines against the SARS-CoV-2 virus. After all, most of vaccines take more than a decade to be formulated and, in the case of the vaccine against the new coronavirus, in less than a year, at least 34 candidate vaccines appeared in clinical analysis. New vaccine production techniques using DNA and RNA recombination techniques are being implemented in this race. In Brazil, the most widely distributed vaccines approved by Anvisa are AstraZeneca, CoronaVac and Pfizer-BioNTech. The AstraZeneca/Oxford vaccine is composed of a non-replicating viral vector, which consists of a defective chipamzee virus (adenovirus), with a segment of the SARS-CoV-2 genome, responsible for producing the structure present on the viral surface (protein S), being recognized by human cells, triggering an immune response against Coronavirus. The CoronaVac vaccine is composed by the inactivated SARS-CoV-2 virus, along with its complete structure. It is unable to multiply, although it can stimulate the response to produce antibodies. The Pfizer-BioNTech vaccine, on the other hand, consists of a formulated lipid nanoparticle of nucleoside-modified mRNA that encodes the pre-fusion peak glycoprotein of SARS-CoV-2. Despite the small amount of dose applications in Brazil, the Janssen vaccine has recently started its distribution in the country. This is the only vaccine, so far, with a single dose application. It is an adenovirus 26 (Ad26) vector vaccine that contains in its interior genetic material of the S protein contained in the surface spikes of SARS-CoV-2, and that stimulates, after application, the cellular responses of T CD4 + and T CD8 + antibodies. Here, we propose a detailed review of the entire history of vaccination, from Smallpox to Covid-19. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.
ABSTRACT
Introduction: Coronavirus 2 (SARS-CoV-2) is a syndrome of acute respiration that is serious like corona acid ribonucleic detected, made separation and identification in pneumonia sick patients in Wuhan, China in December 2019 (WHO, 2020). Timor-Leste on May 1, 2020, 24 cumulative cases was confirmed, 16 cases recovered, 12 cases are still being treated, and 12 patients experienced psychological pressure from patients and health professional. This study aimed to determine the knowledge of nurses;nursing service and the psychological influence of nurses after providing care for Covid-19 patients. Method: Qualitative research with a phenomenological approach has been used in this study, ten nurses who have worked serving Covid-19 patients participated in this study, and data was collected using interview guidelines, voice recorder, deep-interview, data analysis techniques by organizing data, grouping, categorical data, topic and answer formulation, data assessment and writing the results. Result: The majority of nurses understand and apply Covid-19 prevention, but some are confused the cause. Have not carried out nursing care according to the standards of the International Counsel of Nursing (ICN) and the Timor-Leste Nursing Association, as (assessment, diagnosis, intervention, implementation, and nursing evaluation), reasoned: new job, no format, less manpower, no orientation from senior, emergency time. The majority experienced psychological effects after providing care to the Covid-19 patient. Conclusion: This study concluded that nurses understand Covid-19, the nursing care implementation is not yet based on ICN and ETNA standards and after returning home the nurses experienced psychological effects. © 2022, Sanglah General Hospital. All rights reserved.
ABSTRACT
In contemporary times, traditional learning methods have been losing space to more innovative environments, demanding from the professor the insertion of more interactive strategies in the teaching and learning process, based on the dialogical relationship between the actors of the educational dynamic. The objective of this research was to understand the impact of the use of digital technologies on the apprehension of information, on the part of undergraduate nursing students (face-to-face), from private institutions, in the city of Palmas - TO, during the Covid-19 pandemic. It is a quanti-qualitative, descriptive, exploratory research. The adopted methodological procedures were: specific literature review and questionnaire. The research revealed that during the period that universities were required to implement remote classes, students realized that these technologies are supports in the construction of knowledge and in the learning process. But some obstacles were determinant in this process, evidenced, mainly, by the precarious access to the internet and the non-adaptation to the methodology adopted by the professors in the remote modality.
ABSTRACT
Leisure Physical Activities are important strategies for disease prevention, health promotion, well-being, socialization and personal development. However, in 2020, programs with face-to-face services were suspended due to the coronavirus, among them, the Segundo Tempo Universitario Program, which required the planning/preparation/implementation of a project adapted to the pandemic reality. This manuscript aims to present and describe the planning/preparation and implementation of the offer of Systematized Physical Leisure Activities and asynchronous guidelines during the pandemic. Structured in three phases (diagnosis, elaboration and implementation) it was carried out using Information and Communication Technologies, with asynchronous assistance - video classes. To do so, it resorted to the flow - lesson plan, recording of video lessons, hosting on YouTube and publication on the Facebook page. It is concluded that the project, through the new reality imposed by the coronavirus, created an alternative for university students to occupy their available time with systematized Physical Leisure Activities in safety, maintaining social distance, favoring the promotion of health, well-being, socialization family and personal development.
ABSTRACT
Background: Recent studies reported poor to moderate humoral response after two vaccine doses in heart transplant recipients (HTR). Currently, French healthcare authorities recommend 2 and 3 vaccine injections for transplant recipients with and without prior SARS-CoV-2 infection, respectively. This study aimed to evaluate level and durability of humoral immunity with this vaccination strategy. Methods: This single-center cohort study included HTR followed at Paris Bichat hospital between January 2020 and September 2021. Analyses were performed using automated immunoassays (Abbot) to quantify anti-spike IgG (cut-off ≥ 7.1 BAU/mL) and anti-nucleocapsid IgG (cut-off index > 0.49), respectively. Categorical variables were described as number (%) and continuous variables with median (IQR). Results: A total of 181 HTR (75.7% males, age 58 y [47-66]) transplanted between June 1990 and June 2021, with cardiomyopathy (n=95), coronary artery disease (n=61), valvular cardiomyopathy (n=19) or other transplant indications were included. Median time from transplantation to first vaccine dose was 4.2 y [1.8-6.6]. 143 HTR (79%) had no SARS-CoV-2 infection history (HTRn) and 38 (21%) contracted the infection (HTRi) (56% before and 42% after vaccination initiation). After 2 vaccine injections, anti-S IgG seroconversion was observed for only 16% (n=12/76) of HTRn. Overall, anti-S IgG titers were lower in HTRn than in HTRi (0.5 [0.2-2.6] vs 578 [1.4-4449] BAU/mL, respectively, p=0.0001). The 3rd vaccine dose enabled to obtain 42% (n=33/72) of seroconversion among HTRn with median anti-S titers of 3.2 BAU/mL [0.4-35.0]. Only half seroconverters HTRn reached the 260 BAU/mL cut-off chosen by French authorities to define vaccination efficacy. Interestingly, these patients seem to have a sustained humoral response 4 months after the 3rd dose. Conclusion: This study gives new insights on the effect of the 3rd vaccine dose in HTR with low rate of seroconversion and low titers of anti-S IgG but sustained humoral response when seroconversion occurs. Studies on vaccine efficacy against SARS-CoV-2 variants and cell-mediated immune response in this cohort are ongoing.
ABSTRACT
This article discusses the transition of the public schools that attend children through the COVID-19 pandemic. It problematizes Brazil's Ministry of Education's narrative, using him as an example of post-truth that creates a scenario of sanitary security to justify a return of presential classes. The text maps the distortions, inventions and misinterpretations of data, strategies to produce the post-truth, presented by the MEC, the SEED/PR and the SEDUC/AM, contrasting these speeches with information that shows the real scenario of the pandemic in Brazil, taken from the Ministry of Health, scientific journals and official news agencies. It considers the decision of the immediate return an attempt of hiding the situation of the emergency remote education (ERE), as well as the lack of planning and investment in the recommended health conditions, exposed in official documents and research. To build this thesis, it searches the Statistical Synopsis of the Educational Response to the Pandemic of COVID-19 in Brazil, Basical Educational data that show some aspects of the ERE in the Brazilian municipal network, from Parana and Amazonas, which concentrate a large part of children. To support this analysis, it is used the concepts of biopolitics and necropolitcs, which trigger the State racism. They conclude that the argument of defending the future of the children legitimizes the exposure of them, their families and the professionals of the school, letting subalternized population die.
ABSTRACT
This article investigates the unequal conditions of digital access among students in the current pandemic context. The objective is to understand digital access as a cultural capital that generates privileges in a context whose 'teaching modality' is remote. The hypothesis assessed assumes that the stratification of access to digitally based technologies works as a mechanism through which school inequalities would widen. Empirically, the article focuses on the socioeconomic conditions of internet access, use of smartphones, tablets and / or computers among high school students at the Escola de Aplicacao/UFPA. The data used in the elaboration of the analyzes that support this research come from a questionnaire, the result of which reveals the precariousness of access to digital resources by a significant portion of these students. The article concludes that the developments of Covid-19, above all, for the empirical field analyzed, suppose the gap in the link between social origin and school inequalities.
ABSTRACT
The article presents the Gender and Sexuality Project of the Escola de Aplicação da FEUSP, created in the early 1990s under the title Adolescent Sexual Orientation. Based on interviews with two teachers involved in the project, as well as the analysis of school documents, the article discusses the challenges, transformations and advances of this discussion at school along almost 30 years of debate with adolescents and young people on topics such as gender identity, sexuality, teenage pregnancy and health. Through the memory of two teachers at the school, we reconstruct some transformations and challenges faced by the project since its creation, in the 1990s, until 2020, already in the COVID-19 pandemic context. © 2021 Federal University of Fronteira Sul. All rights reserved.
ABSTRACT
The rapid spread of SARS-CoV-2/COVID-19 in the first months of 2020 overburdened health systems worldwide. The absence of vaccines led public authorities to respond to the pandemic by adopting nonpharmaceutical interventions, mainly social distancing policies. Yet concerns have been raised on the economic impact of such measures. Considering the impracticability of conducting controlled experiments to assess the effectiveness of such interventions, mathematical models have played an essential role in helping decision makers. Here we present a simple modified SIR (susceptible-infectious-recovered) model that includes social distancing and two extra compartments (hospitalized and dead due to the disease). Our model also incorporates the potential increase in the mortality rate due to the health system saturation. Results from numerical experiments corroborate the striking role of social distancing policies in lowering and delaying the epidemic peak, thus reducing the demand for intensive health care and the overall mortality. We also probed into optimal social distancing policies that avoid the health system saturation and minimize the economic downturn. © 2021 Institute of Computer Science Izhevsk. All rights reserved.
ABSTRACT
In the same period, 1116 patients notified by SARS used this drug, with 992 (89%) starting treatment within 48h of hospitalization. B Background: b Influenza is an acute respiratory infection caused by viruses A, B, and C. Influenza surveillance in Brazil is sentinel surveillance of influenza syndrome (FS), sentinel surveillance of severe acute respiratory syndrome (SARS) in patients admitted to the unit of intensive care and surveillance of SARS in hospitalized patients. [Extracted from the article] Copyright of International Journal of Infectious Diseases is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
ABSTRACT
Based on the assumption that Covid-19 is also configured in a socially imposed condition, this research aims to analyze the prevalence of coronavirus infection in Pará, based on data on education, class and color/race of the test population positive for Covid-19. In order to meet the purpose of this work, we launched the following research problem: does the pandemic, in the Pará context, affect everyone without discrimination of class, color/race and education? The hypothesis assessed assumes that coronavirus infection in Pará is not as democratic as many like to make it seem, rather, on the contrary, they discriminate both in terms of its contagion and prevention, as well as its expansion and mitigation. In summary, the article concludes that there is an uneven distribution among the groups affected by the pandemic, with a focus on populations that are most vulnerable.
ABSTRACT
This study aimed to analyze how meteorological conditions such as temperature, humidity and rainfall can affect the spread of COVID-19 in five Brazilian (São Paulo, Rio de Janeiro, Brasília, Manaus and Fortaleza) cities. The cities selected were those with the largest number of confirmed cases considering data of April 13. Variables such as number of cumulative cases, new daily cases and contamination rate were employed for this study. Our results showed that higher mean temperatures and average relative humidity favored the COVID-19 transmission, differently from reports from coldest countries or periods of time under cool temperatures. Thus, considering the results obtained, intersectoral policies and actions are necessary, mainly in cities where the contamination rate is increasing rapidly. Thus, prevention and protection measures should be adopted in these cities aiming to reduce transmission and the possible collapse of the health system.